One has to wonder who checks the costing that Novartis uses to justify the price of its Kymriah Cancer Drug. What would Robert Koch, Louis Pasteur or Alexander Fleming make of this behaviour?
https://www.bloomberg.com//news/articles/2017-08-30/cancer-breakthrough-heralds-new-era-of-cures-costs-and-choices
Government Takes a Stake in 6 More Companies, New Total Is 30 Companies
-
The Commerce Department reports government stakes in six more companies.
7 hours ago
No comments:
Post a Comment